Eastern Europe and Central Asia (EECA) INTERACT conference

尽管东欧和中亚(EECA)的大多数国家都专注于扩大对 抗逆转录病毒治疗用于预防和治疗艾滋病毒，世卫组织警告称，艾滋病毒急剧上升 该地区的结核病合并感染对这两种大流行应对措施都构成了严重威胁。 推进应对措施需要临床、流行病学、社会和实施研究来提供信息 针对当地情况量身定做的流行病应对措施。有具体的机会来改善艾滋病毒的反应 整个EECA包括1)在诊断、治疗和管理方面培训当地医生和科学家 艾滋病毒携带者2)开展实施科学以优化方案投资3)确保 循证公共卫生政策和方案，以减少整个非洲经济共同体与艾滋病毒和结核病有关的差距。 首届EECA互动研讨会于2019年在哈萨克斯坦举行，灵感来自兴趣的成功 每年在不同的非洲国家举行的会议，受益于NIH对 好几年了。EECA InterAct 2019年汇集了临床医生、政策制定者、早期职业生涯和高级 来自该区域的研究人员和民间社会成员，以及来自西欧和北方的科学家 美国，分享艾滋病毒、结核病和丙型肝炎领域的关键发现和经验。 是创新和非正式的，为人们在这两天的参与奠定了基础，重点是 该区域面临着独特的问题，并找到了改进解决办法的途径。 EECA InterAct 2022研讨会将是一次高质量、以区域为重点的科学国际会议 在明斯克，为该地区的科学界提供：1)平台，讨论和确定共同的 解决整个区域艾滋病毒诊断、治疗和预防方面的执行挑战 如结核病、肝炎和更广泛的健康；2)为职业生涯早期的临床医生和 研究人员分享他们在当地环境中的经验和发现；以及3)突出 艾滋病毒、相关疾病和社会行为科学方面的国际专家分享知识和观点。 提议《2022年欧洲经委会行动计划》具有以下具体目标： 1.提供艾滋病毒、结核病和肝炎诊断领域的前沿知识，以及 治疗、发病和预防，为实现95-95-95艾滋病毒做出贡献 遏制目标，减少结核病发病率，并减轻整个EECA中肝炎的影响 2.就向成年人提供和支持艾滋病毒检测服务和临床护理服务交换意见， 青少年和主要艾滋病毒携带者人群，以实现95-95-95目标 3.促进主要研究人员和代表潜在研究人员之间的新的研究互动 未来在东欧和中亚地区医疗保健和研究方面的科学领导地位。 4.在整个欧洲经济和社会事务部建立研究和临床能力。

Although most countries across Eastern Europe and Central Asia (EECA) are focused on scaling up access to antiretroviral treatment for the prevention and treatment of HIV, the WHO has warned that the sharp rise in HIV and tuberculosis coinfections across the region represents a critical threat to both pandemic responses. Advancing the response necessitates clinical, epidemiological, social, and implementation research to inform epidemic responses tailored to local contexts. There are specific opportunities to improve the HIV response across EECA including 1) training local physicians and scientists in the diagnosis, treatment, and management of individuals with HIV 2) conducting implementation science to optimize program investments 3) ensuring evidence-informed public health policy and programming to reduce HIV and TB-related disparities across EECA. The first EECA INTERACT Workshop was held in Kazakhstan in 2019, inspired by the success of the INTEREST conferences, held annually in different African countries each year, that have benefitted from NIH support for several years. EECA INTERACT 2019 brought together clinicians, policy makers, early career and senior researchers, and members of civil society from the region, along with scientists from Western Europe and North America, to share pivotal findings and experiences in the field of HIV, tuberculosis, and hepatitis C. INTERACT was innovative and informal, setting the stage for people to participate throughout the two days, focusing on unique issues facing the region and finding paths forward to solutions for improvement. The EECA INTERACT 2022 workshop will be a high-quality, regionally-focused scientific international meeting in Minsk, providing the region’s scientific communities with: 1) platforms to discuss and identify common solutions to implementation challenges across the region in HIV diagnosis, treatment, and prevention, as well as tuberculosis, hepatitis, and health more generally; 2) opportunities for early-career clinicians and researchers to share their experiences and findings from local settings; and 3) mechanisms for prominent international experts in HIV, related conditions, and social behavioral science to share knowledge and views. EECA Interact 2022 is being proposed with the following specific aims: 1. To provide cutting-edge knowledge in the fields of HIV, tuberculosis, and hepatitis diagnosis and treatment, pathogenesis, and prevention, in order to contribute to achieving the 95-95-95 HIV viral suppression goal, reducing tuberculosis incidence, and lessening the impact of hepatitis across EECA 2. To exchange ideas on providing and supporting HIV testing services and clinical care provision to adults, adolescents, and key populations living with HIV to achieve the 95-95-95 goals 3. To foster new research interactions among leading investigators and those who represent the potential future scientific leadership for health care and research in the Eastern Europe and Central Asia region. 4. To build research and clinical capacity across EECA.